Home › Employers › Wise Vision Care of Hoboken PA
Wise Vision Care of Hoboken PA: H-1B salaries and sponsorship
Wise Vision Care of Hoboken PA filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $164,860.
Does Wise Vision Care of Hoboken PA sponsor H-1B visas?
Wise Vision Care of Hoboken PA filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jan 19, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Optometrist | 4 | $164,860 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $160,014 |
| FY2024 | 1 | $169,707 |
| FY2026 | 1 | $174,491 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Optometrist | $174,491–$239,200 E-3 · Level IV | Hoboken, NJ | Jan 19, 2026 | Mar 10, 2026 | Certified |
| Optometrist | $169,707–$228,800 E-3 · Level IV | Hoboken, NJ | Aug 14, 2024 | Sep 16, 2024 | Certified |
| Optometrist | $160,014–$228,800 E-3 · Level IV | Hoboken, NJ | Mar 22, 2023 | Mar 27, 2023 | Certified |
| Optometrist | $160,014–$228,800 E-3 · Level IV | Hoboken, NJ | Mar 13, 2023 | Mar 27, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).